Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2006-10-02
2011-12-06
Aeder, Sean E (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
Reexamination Certificate
active
08071732
ABSTRACT:
Disclosed are methods and compositions for the detection, diagnosis, prognosis, and therapy of hematological malignancies, and in particular, B cell leukemias, lymphomas and multiple myelomas. Disclosed are compositions, methods and kits for eliciting immune and T cell responses to specific malignancy-related antigenic polypeptides and antigenic polypeptide fragments thereof in an animal. Also disclosed are compositions and methods for use in the identification of cells and biological samples containing one or more hematological malignancy-related compositions, and methods for the detection and diagnosis of such diseases and affected cell types. Also disclosed are diagnostic and therapeutic kits, as well as methods for the diagnosis, therapy and/or prevention of a variety of leukemias and lymphomas.
REFERENCES:
patent: 4742000 (1988-05-01), Greene
patent: 5342761 (1994-08-01), MacLeod
patent: WO 00/17222 (2000-03-01), None
patent: WO 00/40716 (2000-07-01), None
patent: WO 01/24811 (2001-04-01), None
patent: WO 01/38490 (2001-05-01), None
patent: WO 01/60397 (2001-08-01), None
Dahl et al (the Journal of Immunology, Jan. 1992, 148(2): 597-603).
Davis, R.S. et al., “Identification of a family of Fc receptor homologs with preferential B cell expression,”Proc. Natl. Acad. Sci. USA98(17): 9772-9777, Aug. 14, 2001.
EMBL Database, Accession No. AAE00506, Jul. 31, 2001. Retrieved from EBI.
EMBL Database, Accession No. AAE09241, Nov. 19, 2001. Retrieved from EBI.
EMBL Database, Accession No. AAY94001, Oct. 20, 2000. Retrieved from EBI.
GenBank Database, Accession No. AF209720.1, Jan. 19, 2000.
GenBank Database, Accession No. AF319438, Feb. 6, 2001.
GenBank Database, Accession No. AF319438, Feb. 6, 2001.
GenBank Database, Accession No. AF319439, Feb. 6, 2001.
GenBank Database, Accession No. AF397452, Aug. 22, 2001.
GenBank Database, Accession No. AF397453, Aug. 22, 2001.
GenBank Database, Accession No. AF459633, Jan. 13, 2002.
GenBank Database, Accession No. AI141708.1, Sep. 28, 1998.
GenBank Database, Accession No. AW384715.1, Feb. 6, 2000.
GenBank Database, Accession No. AW405794.1, Feb. 8, 2000.
GenBank Database, Accession No. AY043464, Sep. 8, 2001.
GenBank Database, Accession No. AY043465, Sep. 8, 2001.
GenBank Database, Accession No. AY043466, Sep. 8, 2001.
GenBank Database, Accession No. K01326.1, Jun. 13, 1985.
GenBank Database, Accession No. L38562.1, Jul. 15, 1991.
GenBank Database, Accession No. R48079.1, May 24, 1995.
GenBank Database, Accession No. X06876.1, Apr. 2, 1988.
GenBank Database, Accession No. X57804.1, Jul. 15, 1991.
GenBank Database, Accession No. X57820.1, Jul. 15, 1991.
Geneseq Database (Derwent), Accession No. AAQ22491, Jul. 31, 1992.
Hatzivassiliou, G. et al., “IRTA1 and IRTA2, Novel Immunoglobuline Superfamily Receptors Expressed in B Cells and Involved in Chromosome 1q21 Abnormalities in B Cell Malignancy,”Immunity14: 277-289, Mar. 2001.
Tockman, M.S. et al., “Considerations in Brining a cancer Biomarker to Clinical Applications,”Cancer Research52(Suppl.): 2711s-2718s, May 1, 1992.
Xu, M-j. et al., “Molecular Cloning and Characterization of SPAP1, an Inhibitory Receptor,”Biochemical and Biophysical Research Communications280: 768-775, 2001.
GenBank Database, Accession No. AB027233, Jun. 21, 2001.
Miller, I.J. et al., IRTs: A new family of Fc-related cell-surface receptors expressed in B cells and implicated in lymphogenesis,Blood96(11): 499a, Abstract No. 2149, Nov. 2000.
Algate Paul A.
Carter Lauren
Clapper Jonathan D.
Gaiger Alexander
Mannion Jane
Aeder Sean E
Corixa Corporation
SEED IP Law Group PLLC
LandOfFree
Compositions and methods for the detection, diagnosis and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for the detection, diagnosis and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for the detection, diagnosis and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4262624